PPE18 protein of Mycobacterium tuberculosis functions as a virulence factor and is a potential novel therapeutic target
The Journal of Immunology · 2026
DOI: 10.1093/jimmun/vkaf146 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Immunology, 2026. Verfasst von Akshay Girish Manikoth und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Cell Biology, BRIC-Centre for DNA Fingerprinting and Diagnostics, Biotechnology Research and Innovation Council, Uppal, Hyder…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Virulence Factors, Antigens, Bacterial, Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 118 Literaturangaben. Gefördert von: Science and Engineering Research Board, Department of Science and Technology, Council of Scientific and Industrial Research, Department of Biotechnology.
Abstract (Originalsprache)
Mycobacterium tuberculosis (Mtb) is an intracellular pathogen that employs several strategies to evade the host immune system to establish a favorable niche inside the macrophages. One of the major immune evasion strategies involves induction of T helper 2 (Th2)–type response, which in turn downregulates host’s antimycobacterial Th1-type response. Approximately 10% of the Mtb genome is made up of the PE (proline-glutamine))/PPE (proline-proline-glutamine) family of proteins, whose functions are still not fully understood. PPE18, a member of this family was found to activate interleukin-10/Th2-type responses by interacting with TLR2 11 to 15 leucine-rich repeat domain. PPE18 was found to inhibit phagosomal acidification and major histocompatibility complex class II–mediated antigen presentation, allowing the bacterium to persist inside macrophages. Mice infected with ppe18 knockout strain of Mtb had lower bacterial burden and better survival rate. In this review, we highlight the functional importance of PPE18 in mycobacterial virulence and explore the potential of PPE18 as a target for therapeutic drug and vaccine development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Cell Biology, BRIC-Centre for DNA Fingerprinting and Diagnostics, Biotechnology Research and Innovation Council, Uppal, Hyderabad, Telangana, India.
- Graduate Studies, Manipal Academy of Higher Education, Manipal, Karnataka, India.
- Molecular Biology Division, ICMR-National Institute of Nutrition, Indian Council of Medical Research, Tarnaka, Hyderabad, Telangana, India.
ORCID-Profile: Brahmaji Sontyana, Sangita Mukhopadhyay
Förderung
- Science and Engineering Research Board, Department of Science and Technology
- Council of Scientific and Industrial Research
- Department of Biotechnology
- Indian Council of Medical Research
- CDFD by Department of Biotechnology
- Scientific and Industrial Research
Zitieren
APA
Manikoth, A. G., Sontyana, B., Shrivastava, R., Ghosh, S., & Mukhopadhyay, S. (2026). PPE18 protein of Mycobacterium tuberculosis functions as a virulence factor and is a potential novel therapeutic target. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf146
Vancouver
Manikoth AG, Sontyana B, Shrivastava R, Ghosh S, Mukhopadhyay S. PPE18 protein of Mycobacterium tuberculosis functions as a virulence factor and is a potential novel therapeutic target. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkaf146
BibTeX
@article{Manikoth2026,
author = {Manikoth, Akshay Girish and Sontyana, Brahmaji and Shrivastava, Rohini and Ghosh, Sudip and Mukhopadhyay, Sangita},
title = {PPE18 protein of Mycobacterium tuberculosis functions as a virulence factor and is a potential novel therapeutic target},
journal = {The Journal of Immunology},
year = {2026},
doi = {10.1093/jimmun/vkaf146}
}
EUVIMED